Oxurion NV operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Oxurion NV with three other
miscellaneous service companies in Europe:
Zealand Pharma A/S
sales of 37.98 million Danish Kroner [US$5.61 million]
of which 100%
(54.88 million Swedish Kronor [US$5.66 million]
SyntheticMR AB (publ)
based in Sweden
(48.30 million Swedish Kronor [US$4.98 million]
During the year ended December of 2018, sales at
Oxurion NV were 5.32 million Euro (US$5.87 million).
decrease of 41.2%
versus 2017, when the company's sales were 9.06 million Euro.